Veracity Capital LLC trimmed its stake in Avantor, Inc. (NYSE:AVTR – Free Report) by 61.9% during the third quarter, Holdings Channel reports. The fund owned 32,580 shares of the company’s stock after selling 53,011 shares during the period. Veracity Capital LLC’s holdings in Avantor were worth $407,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Voss Capital LP purchased a new stake in shares of Avantor in the 2nd quarter worth about $6,057,000. Tredje AP fonden raised its stake in shares of Avantor by 110.7% in the second quarter. Tredje AP fonden now owns 110,981 shares of the company’s stock worth $1,494,000 after purchasing an additional 58,304 shares during the last quarter. Fifth Third Bancorp raised its holdings in shares of Avantor by 1,741.4% during the second quarter. Fifth Third Bancorp now owns 73,141 shares of the company’s stock valued at $984,000 after purchasing an additional 69,169 shares during the last quarter. Swedbank AB grew its holdings in shares of Avantor by 71.4% in the second quarter. Swedbank AB now owns 102,514 shares of the company’s stock worth $1,380,000 after acquiring an additional 42,700 shares during the period. Finally, Stanley Capital Management LLC lifted its stake in shares of Avantor by 42.9% in the 1st quarter. Stanley Capital Management LLC now owns 998,500 shares of the company’s stock worth $16,186,000 after purchasing an additional 300,000 shares during the period. Institutional investors own 95.08% of the company’s stock.
Avantor Price Performance
AVTR stock opened at $11.07 on Friday. Avantor, Inc. has a fifty-two week low of $10.62 and a fifty-two week high of $23.32. The company has a quick ratio of 0.96, a current ratio of 1.49 and a debt-to-equity ratio of 0.65. The stock has a market cap of $7.55 billion, a price-to-earnings ratio of -85.15, a PEG ratio of 3.82 and a beta of 0.93. The business has a 50 day moving average price of $12.25 and a 200 day moving average price of $12.79.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the stock. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $12.00 price target (down previously from $14.00) on shares of Avantor in a report on Thursday, October 30th. Evercore ISI lowered their price objective on Avantor from $16.00 to $14.00 and set an “outperform” rating for the company in a research note on Thursday, October 30th. Jefferies Financial Group downgraded Avantor to an “underperform” rating in a research report on Wednesday. Bank of America lowered Avantor from a “buy” rating to a “neutral” rating and set a $13.00 price target on the stock. in a report on Monday. Finally, Robert W. Baird lifted their price objective on shares of Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $13.97.
View Our Latest Stock Report on Avantor
Insider Buying and Selling
In related news, Director Gregory L. Summe acquired 100,000 shares of the stock in a transaction that occurred on Thursday, October 30th. The shares were acquired at an average price of $11.25 per share, for a total transaction of $1,125,000.00. Following the completion of the purchase, the director directly owned 300,000 shares of the company’s stock, valued at $3,375,000. The trade was a 50.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Sanjeev K. Mehra bought 350,000 shares of the firm’s stock in a transaction dated Friday, December 5th. The stock was acquired at an average cost of $11.09 per share, with a total value of $3,881,500.00. Following the transaction, the director owned 350,000 shares of the company’s stock, valued at $3,881,500. This trade represents a ? increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 1.20% of the company’s stock.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- What is a buyback in stocks? A comprehensive guide for investors
- Qualcomm’s Monster Rally Has a Catch—Can the Stock Keep Climbing?
- How to start investing in penny stocks
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Forget the Chips: 4 Industrial Plays for the AI Rebound
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
